Sidereal Therapeutics, a startup spun out of Dr. Jonathan Barasch's lab, won a $250K XSeed Award. Sidereal is developing first-in-class therapeutics for acute kidney injury and iron-mediated disorders.
Scientists led by Dr. Samuel Sternberg at Columbia University have improved upon a natural system called CRISPR-associated transposase, or CAST. It combines elements of the fabled gene editor with enzymes known as transposases that move so-called ‘jumping genes’ in and out of the genome.
This Month Past News All News
Filter By:
No more items to display.